Even members of Trump’s team have raised red flags. Outgoing FDA Commissioner Scott Gottlieb said Thursday that overturning Obamacare could thwart an initiative to get cheaper forms of insulin on the market. Carl Schmid, an AIDS Institute leader and co-chair of Trump’s HIV advisory board, called the ACA decision “an unfortunate distraction from ending the HIV epidemic initiative.”

“He’s just completely consigning his own initiatives to the ash heap if the ACA goes down,” said Sara Rosenbaum, a health law and policy expert at George Washington University. “It has become the fabric of the health care system.”…

“Trump’s attempt to dismantle the ACA would critically undermine the goal of ending the HIV epidemic in the United States in the near term,” said Rep. Barbara Lee (D-Calif.), co-founder and co-chair of the bipartisan congressional HIV/AIDS caucus.